Uipath Class A (PATH) closed at $12.85 on October 16, 2026, down 6.3% from the previous close, on volume of 28,195,071 shares (30-day average 42,945,557).
Data as of October 16, 2026.
16-Oct-2026
Globe Newswire (Wed, 14-Oct 8:50 AM ET)
Business Wire (Fri, 9-Oct 4:25 PM ET)
Business Wire (Thu, 8-Oct 8:30 AM ET)
UiPath Recognized as a Leader in Analyst Evaluation for Adaptive Process Orchestration Software
Business Wire (Wed, 7-Oct 8:30 AM ET)
Market Chameleon (Tue, 6-Oct 5:07 AM ET)
UiPath Test Cloud Now Available on Oracle Marketplace
Business Wire (Tue, 6-Oct 8:30 AM ET)
Business Wire (Mon, 5-Oct 8:00 AM ET)
UiPath Joins NCQA’s AI Collaborative with an Early Focus on Prior Authorization
Market Chameleon (Thu, 1-Oct 4:44 AM ET)
UiPath Joins NCQA AI Learning Collaborative to Advance Responsible AI in Healthcare
Business Wire (Thu, 1-Oct 8:30 AM ET)
Business Wire (Wed, 30-Sep 8:30 AM ET)
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.
Uipath Class A trades on the NYSE stock market under the symbol PATH.
As of October 16, 2026, PATH stock price declined to $12.85 with 28,195,071 million shares trading.
PATH has a beta of 1.53, meaning it tends to be more sensitive to market movements. PATH has a correlation of 0.07 to the broad based SPY ETF.
PATH has a market cap of $6.70 billion. This is considered a Mid Cap stock.
Last quarter Uipath Class A reported $410 million in Revenue and $.15 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.02.
In the last 3 years, PATH traded as high as $27.87 and as low as $9.20.
The top ETF exchange traded funds that PATH belongs to (by Net Assets): IJH, VTI, VB, VGT, VBK.
PATH has underperformed the market in the last year with a price return of -19.3% while the SPY ETF gained +16.7%. However, in the short term, PATH had mixed performance relative to the market. It has outperformed in the last 3 months, returning +6.8% vs +1.9% return in SPY. But in the last 2 weeks, PATH shares have been beat by the market, returning -2.1% compared to an SPY return of -0.8%.
PATH support price is $13.31 and resistance is $14.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PATH shares will trade within this expected range on the day.
